The Hongkong and Shanghai Hotels (45) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
6 Jan, 2026Executive summary
Operating revenue rose 13% year-over-year to HK$3.3 billion, driven by strong performances in New York, London, and Tokyo, excluding non-recurring residential sales.
Operating EBITDA increased 63% to HK$643 million, while the loss attributable to shareholders narrowed to HK$289 million from HK$448 million year-over-year; underlying loss improved to HK$216 million.
Net assets attributable to shareholders stood at HK$35.5 billion, with a net external debt to total assets ratio of 25%.
No interim dividend was declared due to the underlying loss.
Focus for H2 is on enhancing operational and financial performance, with a strategic review to be announced in early 2026.
Financial highlights
Revenue from operations reached HK$3,281 million, up 13% year-over-year (excluding residential sales).
Operating EBITDA rose 63% to HK$643 million, with overall EBITDA up 19% year-over-year.
Underlying loss narrowed to HK$216 million, mainly due to depreciation and financing charges.
Net cash generated from recurring operating activities increased tenfold year-over-year to HK$366 million.
Net assets per share: HK$21.30; adjusted net assets per share: HK$24.24.
Outlook and guidance
Cautiously optimistic for the second half, with high season expected to benefit Paris, Tokyo, Beverly Hills, and New York.
Geopolitical instability and trade tensions expected to continue impacting Greater China hotels and Istanbul.
Commercial property demand in Hong Kong and The Peak remains strong; continued investment in existing assets planned.
Anticipates continued demand for unique, personalized, and sustainable luxury experiences.
Expense management prioritized in weaker markets.
Latest events from The Hongkong and Shanghai Hotels
- Profitability restored in 2025 with robust revenue and EBITDA growth, supported by Vision 2035.45
H2 202518 Mar 2026 - Revenue surged on London sales, but higher costs and revaluation losses resulted in a net loss.45
H1 20242 Feb 2026 - Revenue up 26–27% to HK$10.3B–HK$10.99B, but net loss of HK$943M; 2025 outlook optimistic.45
H2 20247 Jan 2026